naloxone IM
Selected indexed studies
- High-dose naloxone formulations are not as essential as we thought. (Harm Reduct J, 2024) [PMID:38741224]
- Naloxone and shock. (Crit Care Med, 2000) [PMID:10667551]
- Naloxone Administration by Untrained Community Members. (Pharmacotherapy, 2020) [PMID:31782193]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- High-dose naloxone formulations are not as essential as we thought. (2024) pubmed
- Naloxone and shock. (2000) pubmed
- Naloxone Administration by Untrained Community Members. (2020) pubmed
- A comparison of intramuscular (Zimhi) and intranasal naloxone (Narcan) in reversal of fentanyl-induced apnea: a randomized, crossover, open-label trial. (2025) pubmed
- Naloxone and nalmefene absorption delivered by hollow microneedles compared to intramuscular injection. (2022) pubmed
- Expanding naloxone education in the doctor of pharmacy curriculum. (2022) pubmed
- Pharmacokinetics and pharmacodynamics of intranasal and intramuscular administration of naloxone in working dogs administered fentanyl. (2023) pubmed
- Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review. (2018) pubmed
- Exploring the possible mechanism of low-dose naloxone exposure improving the immune microenvironment of gastric cancer tumors. (2025) pubmed
- Acute Opioid Withdrawal Following Intramuscular Administration of Naloxone 1.6 mg: A Prospective Out-Of-Hospital Series. (2022) pubmed